Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous CD19 Car T-Cell Therapy For Patients With Severe Refractory Systemic Lupus Erythematosus - A Pilot Study

NCT06710717 is registered in ClinicalTrials.gov with National University of Malaysia as lead sponsor.

NCT NCT06710717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous CD19 Car T-Cell Therapy For Patients With Severe Refractory Systemic Lupus Erythematosus - A Pilot Study
Lead sponsor
National University of Malaysia
Phase
Phase 1
Overall status
Recruiting
Start date
January 3, 2025
Completion date
January 2, 2029
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematous (sle)